Targeting the IL-23 pathway in inflammatory bowel disease: from cytokine inhibition to oral IL-23 receptor blockade
- DOI
- 10.1136/egastro-2026-100708
- Published
- 2026-10
- Container
- eGastroenterology
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/egastro-2026-100708,
title = {Targeting the IL-23 pathway in inflammatory bowel disease: from cytokine inhibition to oral IL-23 receptor blockade},
author = {Sailish Honap and Michael Colwill and Axel Dignass and Vipul Jairath and Fernando Magro and Silvio Danese and Laurent Peyrin-Biroulet},
year = {2026},
journal = {eGastroenterology},
doi = {10.1136/egastro-2026-100708},
url = {https://doi.org/10.1136/egastro-2026-100708}
}RIS
TY - JOUR TI - Targeting the IL-23 pathway in inflammatory bowel disease: from cytokine inhibition to oral IL-23 receptor blockade AU - Sailish Honap AU - Michael Colwill AU - Axel Dignass AU - Vipul Jairath AU - Fernando Magro AU - Silvio Danese AU - Laurent Peyrin-Biroulet PY - 2026 JO - eGastroenterology DO - 10.1136/egastro-2026-100708 UR - https://doi.org/10.1136/egastro-2026-100708 ER -
APA
Honap, S., Colwill, M., Dignass, A., Jairath, V., Magro, F., Danese, S., & Peyrin-Biroulet, L. (2026). Targeting the IL-23 pathway in inflammatory bowel disease: from cytokine inhibition to oral IL-23 receptor blockade. eGastroenterology. https://doi.org/10.1136/egastro-2026-100708
Source records
- crossref · retrieved 2026-11-10T08:12:21.732Z